Author

Gregory S. Hawk

University of KentuckyORCID 0000-0001-8935-9965Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Ailing JiiD· 1 shared Andrew Paul DeFilippisiD· 1 shared Arshed Ali QuyyumiiD· 1 shared Ayman Samman Tahhan· 1 shared Clairity VoyiD· 1 shared David M HensoniD· 1 shared Hui YuiD· 1 shared Katherine L. ThompsoniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Ailing JiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preserved CETP Activity and Early Serum Amyloid A are Associated with Improved Outcomes in Sepsis-Associated ARDS

Ailing Ji, Osemwenoyenmwen Abu, Luke W. Meredith, Hui Yu, Clairity Voy, Maria E. C. Bruno, Scott M. Gordon, Gregory S. Hawk, Marlene E. Starr, Preetha Shridas

This study identifies CETP activity and early SAA levels as prognostic biomarkers in sepsis-associated ARDS, showing they predict improved survival and reduced disease severity.

bioRxiv · Sep 17, 2026 · PreprintBiochemistry

Identification and characterization of a human antibody profile inversely associated with adverse cardiovascular events

David M Henson, Katherine L. Thompson, Ayman Samman Tahhan, Ryan Marion, Tabarak Azawi, Peng Yeh, Gregory S. Hawk, Andrew Paul DeFilippis, Arshed Ali Quyyumi, Vincent J. Venditto

The paper identifies a human antibody profile inversely associated with adverse cardiovascular events in two cohorts, showing it predicts higher risk when levels are low.

bioRxiv · Sep 6, 2026 · PreprintImmunology